Search results for " Mediterranean spotted fever"

showing 6 items of 6 documents

Coronary involvement in Mediterranean spotted fever

2011

Mediterranean spotted fever (MSF) is a tick-borne acute febrile disease caused by Rickettsia conorii and characterized by fever, a maculo-papular rash and a black eschar at the site of the tick bite. We describe the case of a 3-year-old boy with MSF who developed a transient right coronary artery ectasia. The patient was brought to the hospital after four days of fever and mild myalgia of the legs. The suspicion of MSF arose due to the presence of a maculo-papular skin rash and treatment with oral clarithromycin was started. After four days fever persisted and the differential diagnosis of Kawasaki syndrome was considered. Echocardiography showed a dilated right coronary artery with hyperre…

MaleRickettsia conoriiSettore MED/38 - Pediatria Generale E SpecialisticaItalyEchocardiographyChild PreschoolHumansCoronary Artery DiseaseBoutonneuse FeverCoronary involvement Mediterranean spotted feverDilatation Pathologic
researchProduct

Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever.

2009

Several studies have demonstrated that cellular immunity plays a critical role in the protective immune response against Rickettsia conorii. Immune CD4+ and CD8+ T cells are both involved in the control of rickettsial infection (38). Perivascular infiltrated CD4+ and CD8+ T lymphocytes, macrophages, and natural killer cells produce chemokines and cytokines that activate endothelial rickettsicidal activities. Infected human cells, including endothelial cells, hepatocytes, and macrophages, activated by gamma interferon (IFN-γ), tumor necrosis factor alpha (TNF-α), and interleukin-1β (IL-1β), kill intracellular rickettsiae by one or a combination of three mechanisms, involving nitric oxide syn…

AdultMaleMicrobiology (medical)Meningitidesgene polymorphismgene polymorphisms; mediterranean spotted fevermedicine.medical_treatmentClinical BiochemistryImmunologyBiologyBoutonneuse FeverPolymorphism Single NucleotideInterferon-gammaImmune systemInterferonmedicineHumansImmunology and AllergyCytotoxic T cellSicilyTumor Necrosis Factor-alphaMiddle AgedInterleukin-10mediterranean spotted feverInterleukin 10CytokineImmunologyFemaleTumor necrosis factor alphaDisease SusceptibilityMicrobial ImmunologyCD8medicine.drug
researchProduct

A severe case of Israeli spotted fever with pleural effusion in Italy

2021

Abstract Background The most common Italian rickettsiosis is Mediterranean Spotted Fever (MSF). MSF is commonly associated with a symptom triad consisting of fever, cutaneous rash, and inoculation eschar. The rash is usually maculopapular but, especially in severe presentations, may be petechial. Other typical findings are arthromyalgia and headache. Herein, we describe for the first time an unusual case of Israeli spotted fever (ISF) associated with interstitial pneumonia and pleural effusion in which R. conorii subsp. israelensis was identified by molecular methods in the blood, as well as in the pleural fluid. Case presentation A 72-year-old male presented with a 10-day history of remitt…

Microbiology (medical)Malemedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaItaly Mediterranean spotted fever Pleural effusion Rickettsia Rickettsiales RickettsiosisSettore MED/17 - Malattie InfettivePleural effusionmedicine.medical_treatmentRickettsialesThoracentesisCase ReportEscharRickettsiosisBoutonneuse FeverMedicineHumansRickettsiaAgedbusiness.industryMediterranean spotted feverRickettsia InfectionsGeneral MedicinePetechial rashSpotted Fever Group Rickettsiosismedicine.diseaseRashDermatologyPleural effusionSpotted feverPneumoniaInfectious DiseasesRickettsiosisItalymedicine.symptombusinessInfection
researchProduct

Israeli Spotted Fever in Sicily. Description of two cases and minireview

2017

Mediterranean spotted fever (MSF) is endemic in Italy, where Rickettsia conorii subsp. conorii was thought to be the only pathogenic rickettsia and Rhipicephalus sanguineus the vector and main reservoir. R. conorii subsp. israelensis, which belongs to the R. conorii complex, is the agent of Israeli spotted fever (ISF); apart from Israel, it has also been found in Italy (Sicily and Sardinia) and in different regions of Portugal. We describe here two severe cases of ISF which occurred in otherwise healthy Italian adults. Their characteristics are analyzed and discussed in the light of other 91 cases found through a systematic review of international literature.

AdultMaleMicrobiology (medical)Settore MED/17 - Malattie InfettiveIsraeli spotted fever; Mediterranean spotted fever; Rickettsia israelensis; Microbiology (medical); Infectious DiseasesRhipicephalus sanguineus030231 tropical medicineBoutonneuse Feverlcsh:Infectious and parasitic diseases03 medical and health sciences0302 clinical medicinemedicineInternational literatureAnimalsHumanslcsh:RC109-216Rickettsia israelensi030212 general & internal medicineIsraelSicilyNormal rangebiologyMediterranean spotted feverGeneral Medicinebiology.organism_classificationmedicine.diseaseIsraeli spotted feverVirologySpotted feverBoutonneuse feverRickettsia conoriiInfectious DiseasesRickettsiaRickettsia israelensisVector (epidemiology)FemaleRickettsia conoriiInternational Journal of Infectious Diseases
researchProduct

Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial

2001

Fifty-one children with Mediterranean spotted fever (MSF) were randomized to receive either clarithromycin, 15 mg/kg/ day orally in 2 divided doses, or chloramphenicol, 50 mg/ kg/day orally in 4 divided doses, for 7 days. Mean time to defervescence was 36.7 h in the clarithromycin group and 47.1 h in the chloramphenicol group (P = .047). Clarithromycin could be an acceptable therapeutic alternative to chloramphenicol and to tetracyclines for children aged <8 years with MSF.

Microbiology (medical)Malemedicine.medical_specialtyBoutonneuse FeverGastroenterologylaw.inventionRandomized controlled trialOral administrationlawClarithromycinInternal medicineClarithromycinmedicineHumansChildAntibacterial agentclarithromycin Mediterranean spotted feverbusiness.industryChloramphenicolmedicine.diseaseSpotted feverSurgeryAnti-Bacterial AgentsBoutonneuse feverInfectious DiseasesRickettsiosisChloramphenicolChild PreschoolFemalebusinessmedicine.drug
researchProduct

First case of Mediterranean spotted fever-associated rhabdomyolysis leading to fatal acute renal failure and encephalitis

2014

SummaryMediterranean spotted fever (MSF) is a tick-borne zoonosis caused by Rickettsia conorii. In Italy, about 400 cases are reported every year and nearly half of them occur in Sicily, which is one of the most endemic regions. Although MSF is mostly a self-limited disease characterized by fever, skin rash, and a dark eschar at the site of the tick bite called a ‘tache noire’, serious complications are described, mainly in adult patients. Nevertheless, severe forms of the disease with major morbidity and a higher mortality risk have been described. We report a fatal case of MSF complicated by rhabdomyolysis, acute renal failure, and encephalitis in an elderly woman.

Microbiology (medical)medicine.medical_specialtyAcute renal failure; Encephalitis; Mediterranean spotted fever; Rhabdomyolysis; Rickettsia conoriiSettore MED/17 - Malattie InfettiveEscharTickBoutonneuse FeverRhabdomyolysislcsh:Infectious and parasitic diseasesAcute renal failureEncephalitimedicineHumanslcsh:RC109-216Agedbiologybusiness.industryZoonosisMediterranean spotted feverGeneral MedicineAcute Kidney Injurymedicine.diseasebiology.organism_classificationRashDermatologyVirologyRhabdomyolysiSpotted feverRickettsia conoriiInfectious DiseasesEncephalitisFemalemedicine.symptombusinessRickettsia conoriiRhabdomyolysisEncephalitisInternational Journal of Infectious Diseases
researchProduct